By visiting our site, you agree to our privacy policy regarding cookies, tracking statistics, etc.
At Haermonics you will be. As a clinical stage medtech company developing innovative therapies to prevent post-operative cardiac surgery complications. What we do matters. What we do actually does save lives. Not a bad motivation to get going every morning.
In fact, every day 250 patients die from postoperative heart surgery complications caused by residual blood and clots in the pericardial cavity. Complications that we can help prevent. That’s why we’re looking to expand our teams with these positions:
We’re happy to say that our PURE-AT-HEART recruitment campaign has raised €2500 for the Dutch Heart Foundation (Hartstichting) and its life-saving research!
And we’re looking forward to some super new Haermonics hires!
Haermonics is transforming postoperative open heart surgery care with the PURE System, an innovative flush-therapy device. By continuously cleaning the pericardial cavity, it prevents blood clots and hematomas, significantly reducing complications and eliminating the need for unnecessary reoperations. Clinically validated through trials showing a 59% reduction in blood loss and zero reoperations, the PURE System is poised to set a new standard in cardiac surgery recovery.
As the CEO of Haermonics, you will lead the company’s journey to commercialize and scale this groundbreaking technology across Europe and the US. You will develop and execute the business strategy, drive fundraising, negotiate with key stakeholders, and create partnerships to bring the PURE System to market. You will also lead a team of professionals across R&D, QA/RA, marketing, and clinical functions, ensuring alignment and driving innovation. Working together with advisors, partners and leveraging a strong support network, you will position Haermonics as a leader in postoperative care after open heart surgery.
Core responsibilities include
Key Competencies
The Opportunity
This is your chance to lead a high-potential MedTech venture with equity-based compensation and access to a robust innovation ecosystem. You will play a critical role in bringing a life-saving solution to patients and redefining the future of cardiac postoperative care.
This is more than just a job—it’s a chance to become a key partner in a highly promising venture. Here’s what we offer:
Why This Matters
Every day, 250 patients lose their lives to preventable complications after open heart surgery. By joining and leading Haermonics, you’ll drive an innovation that not only saves lives but also reshapes cardiac care globally, making recovery safer and more effective for countless patients.
For more information, please contact augusta.poteliunaite@nlc.health